ZTS Q3 2021 Earnings — Zoetis Inc. Revenue & Financial Results | Market Cap Arena

ZTSZoetis Inc.

$52B

Q3 2021 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$2.0B+11.4% YoY

Gross Profit

$1.4B68.5% margin

Operating Income

$728M36.6% margin

Net Income

$552M27.7% margin

EPS (Diluted)

$1.16

QoQ Revenue Growth

+2.2%

Cash Flow

Operating Cash Flow

$653M

Free Cash Flow

$534M

Stock-Based Comp.

$15M

Balance Sheet

Total Assets

$13.7B

Total Liabilities

$9.0B

Stockholders' Equity

$4.7B

Cash & Equivalents

$3.3B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2.0B	$1.8B	+11.4%
Gross Profit	$1.4B	$1.2B	+13.7%
Operating Income	$728M	$664M	+9.6%
Net Income	$552M	$479M	+15.2%

Revenue Segments

Dogs and Cats

$1.1B59%

Cattle

$403M21%

Swine

$153M8%

Poultry

$124M6%

Horses

$60M3%

Fish

$56M3%

Geographic Segments

United States Segment

$1.1B54%

International Segment

$904M46%